T-cells Expressing Anti-CD19 CAR in Pediatric and Young Adults With B-cell Malignancies

Clinical trial NCT02772198 · UNKNOWN

Trial details

NCT number: NCT02772198
Sponsor: Sheba Medical Center
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia, B-precursor Non-Hodgkin Lymphoma, B-cell

Start date: 2016-11-01
Primary completion: 2022-07-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.